Skip NavigationSkip to Content

3D Models of the NCI60 Cell Lines for Screening Oncology Compounds

  1. Author:
    Selby, Michael
    Delosh, Rene
    Laudeman, Julie
    Ogle, Chad
    Reinhart, Russell
    Silvers, Thomas
    Lawrence, Scott
    Kinders, Robert
    Parchment, Ralph
    Teicher, Beverly
    Evans, David
  2. Author Address

    Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Bldg 432,Rm 136,1050 Boyle St, Frederick, MD 21702 USA.NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA.
    1. Year: 2017
    2. Date: Jun
  1. Journal: SLAS DISCOVERY
  2. SAGE PUBLICATIONS INC,
    1. 22
    2. 5
    3. Pages: 473-483
  3. Type of Article: Article
  4. ISSN: 2472-5552
  1. Abstract:

    The NCI60 cell line panel screen includes 60 human tumor cell lines derived from nine tumor types that has been used over the past 20+ years to screen small molecules, biologics, and natural products for activity. Cells in monolayer culture in 96-well plates are exposed to compounds for 48 h, and Sulforhodamine B is used to determine cell viability. Data analysis tools such as COMPARE allow classification of compounds based on the pattern of cell line response. However, many compounds highly active in monolayer cell culture fail to show efficacy in vivo. Therefore, we explored 3D culture of the NCI60 panel as a strategy to improve the predictive accuracy of the screen. 3D cultures more closely resemble tumors than monolayer cultures with tighter cell-cell contact and nutrient and oxygen gradients between the periphery and the center. We optimized the NCI60 cell line panel for generating 3D spheroids of a prespecified diameter (300-500 mu m) in ultra-low attachment (ULA) plates. Spheroids were classified into four categories based on imaging, and concentration response of select agents in 2D and 3D models is presented.

    See More

  1. Keywords:

External Sources

  1. DOI: 10.1177/2472555217697434
  2. WOS: 000401727800003

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel